Beijing Aosaikang Pharmaceutical Statistics
Total Valuation
Beijing Aosaikang Pharmaceutical has a market cap or net worth of CNY 10.14 billion. The enterprise value is 8.42 billion.
Market Cap | 10.14B |
Enterprise Value | 8.42B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Beijing Aosaikang Pharmaceutical has 928.16 million shares outstanding. The number of shares has increased by 19.51% in one year.
Shares Outstanding | 928.16M |
Shares Change (YoY) | +19.51% |
Shares Change (QoQ) | -20.27% |
Owned by Insiders (%) | 1.57% |
Owned by Institutions (%) | 3.96% |
Float | 172.51M |
Valuation Ratios
The trailing PE ratio is 119.47.
PE Ratio | 119.47 |
Forward PE | n/a |
PS Ratio | 6.18 |
PB Ratio | 3.12 |
P/FCF Ratio | 49.42 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 202.62, with an EV/FCF ratio of 41.00.
EV / Earnings | 98.42 |
EV / Sales | 5.09 |
EV / EBITDA | 202.62 |
EV / EBIT | n/a |
EV / FCF | 41.00 |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 2.65.
Current Ratio | 3.73 |
Quick Ratio | 3.42 |
Debt / Equity | 2.65 |
Debt / EBITDA | 1.96 |
Debt / FCF | 0.40 |
Interest Coverage | -15.04 |
Financial Efficiency
Return on equity (ROE) is 1.28% and return on invested capital (ROIC) is -0.87%.
Return on Equity (ROE) | 1.28% |
Return on Assets (ROA) | -0.75% |
Return on Capital (ROIC) | -0.87% |
Revenue Per Employee | 1.69M |
Profits Per Employee | 87,351 |
Employee Count | 979 |
Asset Turnover | 0.47 |
Inventory Turnover | 1.83 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.21% in the last 52 weeks. The beta is 0.35, so Beijing Aosaikang Pharmaceutical's price volatility has been lower than the market average.
Beta (5Y) | 0.35 |
52-Week Price Change | +40.21% |
50-Day Moving Average | 10.37 |
200-Day Moving Average | 10.09 |
Relative Strength Index (RSI) | 50.26 |
Average Volume (20 Days) | 3,896,771 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beijing Aosaikang Pharmaceutical had revenue of CNY 1.65 billion and earned 85.52 million in profits. Earnings per share was 0.09.
Revenue | 1.65B |
Gross Profit | 1.35B |
Operating Income | -42.28M |
Pretax Income | 50.41M |
Net Income | 85.52M |
EBITDA | 39.06M |
EBIT | -42.28M |
Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 1.95 billion in cash and 81.50 million in debt, giving a net cash position of 1.87 billion or 2.01 per share.
Cash & Cash Equivalents | 1.95B |
Total Debt | 81.50M |
Net Cash | 1.87B |
Net Cash Per Share | 2.01 |
Equity (Book Value) | 3.08B |
Book Value Per Share | 3.50 |
Working Capital | 1.78B |
Cash Flow
In the last 12 months, operating cash flow was 366.29 million and capital expenditures -161.03 million, giving a free cash flow of 205.26 million.
Operating Cash Flow | 366.29M |
Capital Expenditures | -161.03M |
Free Cash Flow | 205.26M |
FCF Per Share | 0.22 |
Margins
Gross margin is 81.38%, with operating and profit margins of -2.56% and 5.17%.
Gross Margin | 81.38% |
Operating Margin | -2.56% |
Pretax Margin | 3.05% |
Profit Margin | 5.17% |
EBITDA Margin | 2.36% |
EBIT Margin | -2.56% |
FCF Margin | 12.41% |
Dividends & Yields
Beijing Aosaikang Pharmaceutical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 1.28% |
Buyback Yield | -19.51% |
Shareholder Yield | -19.51% |
Earnings Yield | 0.84% |
FCF Yield | 2.02% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |